PL438609A1 - Kompozycja zawierająca mieszaninę ekstraktów z Vitis vinifera i Vaccinium angustifolium oraz probiotyki dla poprawy funkcji poznawczych - Google Patents
Kompozycja zawierająca mieszaninę ekstraktów z Vitis vinifera i Vaccinium angustifolium oraz probiotyki dla poprawy funkcji poznawczychInfo
- Publication number
- PL438609A1 PL438609A1 PL438609A PL43860921A PL438609A1 PL 438609 A1 PL438609 A1 PL 438609A1 PL 438609 A PL438609 A PL 438609A PL 43860921 A PL43860921 A PL 43860921A PL 438609 A1 PL438609 A1 PL 438609A1
- Authority
- PL
- Poland
- Prior art keywords
- mixture
- extracts
- composition containing
- probiotics
- vitis vinifera
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 239000006041 probiotic Substances 0.000 title abstract 3
- 235000018291 probiotics Nutrition 0.000 title abstract 3
- 235000013473 Vaccinium lamarckii Nutrition 0.000 title abstract 2
- 240000006365 Vitis vinifera Species 0.000 title abstract 2
- 235000014787 Vitis vinifera Nutrition 0.000 title abstract 2
- 239000000284 extract Substances 0.000 title abstract 2
- 235000002532 grape seed extract Nutrition 0.000 title abstract 2
- 241001499782 Vaccinium angustifolium Species 0.000 title 1
- 230000003920 cognitive function Effects 0.000 title 1
- 235000016709 nutrition Nutrition 0.000 abstract 2
- 230000000529 probiotic effect Effects 0.000 abstract 2
- 241000894006 Bacteria Species 0.000 abstract 1
- 241001465754 Metazoa Species 0.000 abstract 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 abstract 1
- 244000177965 Vaccinium lamarckii Species 0.000 abstract 1
- 230000019771 cognition Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/85—Verbenaceae (Verbena family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
- A61K2035/115—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Mycology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Botany (AREA)
- Psychiatry (AREA)
- Molecular Biology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR2007796A FR3112686B3 (fr) | 2020-07-24 | 2020-07-24 | Composition comprenant un mélange d’extraits de Vitis vinifera et de Vaccinium angustifolium et des probiotiques pour améliorer les fonctions cognitives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL438609A1 true PL438609A1 (pl) | 2022-01-31 |
Family
ID=78032387
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL438609A PL438609A1 (pl) | 2020-07-24 | 2021-07-26 | Kompozycja zawierająca mieszaninę ekstraktów z Vitis vinifera i Vaccinium angustifolium oraz probiotyki dla poprawy funkcji poznawczych |
Country Status (5)
| Country | Link |
|---|---|
| AU (1) | AU2021107611A4 (fr) |
| DK (1) | DK202100060U3 (fr) |
| FR (1) | FR3112686B3 (fr) |
| PL (1) | PL438609A1 (fr) |
| WO (1) | WO2022018281A2 (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR3132221A1 (fr) * | 2022-01-28 | 2023-08-04 | Activ'inside | Utilisation d’un mélange de flavanols pour augmenter la concentration de la forme active de la vitamine D, le calcitriol. |
| CN115300532B (zh) * | 2022-09-20 | 2023-10-20 | 中加健康工程研究院(合肥)有限公司 | 具改善阿尔兹海默病认知能力的益生菌剂及其制备方法 |
| FR3146578A1 (fr) * | 2023-03-14 | 2024-09-20 | Laboratoire D'innovation Cosmetique Et Dermatologique | Nouvelle association à base de probiotiques, compositions la contenant et ses utilisations |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2899768B1 (fr) * | 2006-04-14 | 2008-06-20 | Juva Sante Soc Par Actions Sim | Complement alimentaire antioxydant contenant des oligoproanthocyanides, du gamma-tocopherol, des catechines et biflavanes, de l'acide carnosique et du carnosol |
| EP2710901A1 (fr) * | 2012-09-20 | 2014-03-26 | Symrise AG | Composition de supplément diététique |
| FR3042712B1 (fr) | 2015-10-27 | 2019-05-03 | Activ'inside | Agent nutritionnel ou therapeutique particulier comprenant un melange de raisin et de bleuet |
| CN108601372A (zh) * | 2015-10-27 | 2018-09-28 | 特种宠物食品公司 | 用于宠物的协同有效的抗氧化剂组合物 |
| KR20190007412A (ko) * | 2016-03-07 | 2019-01-22 | 네이처스 선샤인 프로덕트, 인크. | 식이 및 운동 후 체중 감량 및 심대사 건강을 향상시키는 방법 및 조성물 |
| CN107334025A (zh) * | 2017-08-08 | 2017-11-10 | 安徽永骏生物科技有限公司 | 一种蓝莓发酵饮料 |
| FR3088540B1 (fr) * | 2018-11-21 | 2023-05-12 | Activinside | UTILISATION EN PRISE UNIQUE D’UNE COMPOSITION comprenant un melange PARTICULIER D’EXTRAIT DE RAISINS ET D’EXTRAIT DE BLEUETS |
-
2020
- 2020-07-24 FR FR2007796A patent/FR3112686B3/fr active Active
-
2021
- 2021-07-23 WO PCT/EP2021/070733 patent/WO2022018281A2/fr active Application Filing
- 2021-07-26 DK DKBA202100060U patent/DK202100060U3/da active IP Right Grant
- 2021-07-26 PL PL438609A patent/PL438609A1/pl unknown
- 2021-07-26 AU AU2021107611A patent/AU2021107611A4/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| WO2022018281A2 (fr) | 2022-01-27 |
| FR3112686A3 (fr) | 2022-01-28 |
| FR3112686B3 (fr) | 2022-07-29 |
| AU2021107611A4 (en) | 2022-01-06 |
| DK202100060U3 (da) | 2021-10-26 |
| WO2022018281A3 (fr) | 2022-03-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL438609A1 (pl) | Kompozycja zawierająca mieszaninę ekstraktów z Vitis vinifera i Vaccinium angustifolium oraz probiotyki dla poprawy funkcji poznawczych | |
| BR112018005195A2 (pt) | lactobacillus plantarum lc27, composição farmacêutica para a prevenção ou tratamento de uma ou mais doenças, composição alimentícia para a prevenção ou tratamento de uma ou mais doenças, método de prevenção ou tratamento de uma ou mais doenças, e uso de uma composição que compreende lactobacillus plantarum lc27 | |
| BR112018015097A2 (pt) | composição e reatores | |
| Ramiah et al. | Effects of two herbal extracts and virginiamycin supplementation on growth performance, intestinal microflora population and fatty acid composition in broiler chickens | |
| RU2010126327A (ru) | Композиция на основе пробиотических бактерий совместно с пребиотиком и ее применение в предупреждении и/или лечении респираторных патологий и/или инфекций и для улучшения функций кишечника | |
| BR112019001984A2 (pt) | bactérias lácticas e a sua utilização para tratamento prevenção, inibição e/ou redução da formação de biofilmes bacterianos | |
| Zhu et al. | Fish oil enhances intestinal barrier function and inhibits corticotropin-releasing hormone/corticotropin-releasing hormone receptor 1 signalling pathway in weaned pigs after lipopolysaccharide challenge | |
| Chiancone et al. | The use of a combination of Vaccinium macracarpon, Lycium barbarum L. and probiotics (Bifiprost®) for the prevention of chronic bacterial prostatitis: a double-blind randomized study | |
| MX2021009443A (es) | Composiciones que contienen bacterias productoras de bacillaeno o preparaciones de las mismas. | |
| DE602004032502D1 (de) | Behandlung von Krebs mit natürlichen Pflanzenprodukten, etherischen Ölen oder Inhaltsstoffen von Pistazia Arten | |
| WO2019022602A8 (fr) | Composition pharmaceutique destinée à être utilisée dans le traitement ou la prévention de carences en vitamines et minéraux chez des patients ayant été soumis à une gastrectomie | |
| BR112022025078A2 (pt) | Agentes de aperfeiçoamento e de manutenção da função cognitiva e da função do hipocampo, alimentos ou bebidas de aperfeiçoamento e de manutenção da função cognitiva e da função do hipocampo, e, uso de uma ou ambas de bifidobacterium breve ferm bp-11175 e uma cultura de bifidobacterium breve ferm bp-11175 | |
| PH12020551849A1 (en) | Wellbeing supplement for postpartum maternal nutrition | |
| PL433015A1 (pl) | Formulacja zawierającego kurkuminoidy ekstraktu z kurkumy sposób jej otrzymywania, napój koncentrat napoju, suplement diety, kompozycja farmaceutyczna zawierająca formulację oraz zastosowanie formulacji suplementach diety i produktach farmaceutycznych aktywujących metabolizm aldehydu octowego | |
| MX2023009007A (es) | Antagonistas de gitr y metodos de uso de los mismos. | |
| PL438420A1 (pl) | Zastosowanie kannabinoidów jako przeciwutleniaczy pełniących funkcje stabilizatorów pozwalających na utrzymanie odpowiedniej jakości, właściwości i trwałości produktów spożywczych (żywności), produktów leczniczych, wyrobów medycznych i kosmetyków. | |
| PL422140A1 (pl) | Zastosowanie totarolu i kompozycja farmaceutyczna zawierająca totarol | |
| BR112018071493A2 (pt) | usos de ácido linoleico (la) e ácido alfa-linolênico (ala) na fabricação de uma composição nutricional, composição nutricional, método para prevenir declínio no funcionamento cognitivo induzido e método para prevenir redução na neurogênese induzida por estresse precoce | |
| WO2021159068A8 (fr) | Composition et méthode d'utilisation des composés germinatifs dans les probiotiques pour réduire l'inflammation chez les êtres humains | |
| PL416198A1 (pl) | Kompozycja farmaceutyczna zawierająca połączenie kwasu hialuronowego i roślinnych fitoestrogenów do aplikacji waginalnej | |
| UA127306U (uk) | Комплексний пробіотичний препарат | |
| PL419333A1 (pl) | Nowy szczep bakterii Bifidobacterium animalis AMT30 i kompozycja zawierająca szczep Bifidobacterium animalis AMT30 | |
| PL437487A1 (pl) | Kompozycja farmaceutyczna oraz jej przeciwwirusowe zastosowanie | |
| PL433819A1 (pl) | Kompozycja bakterii o właściwościach probiotycznych | |
| PL438421A1 (pl) | Zastosowanie kannabinoidów jako przeciwutleniaczy pełniących funkcje czynników pozwalających na utrzymanie odpowiedniej jakości i właściwości produktów spożywczych (żywności), produktów leczniczych, wyrobów medycznych i kosmetyków. |